We found that all tumor cells expressed CD44 and the higher mRNA levels were detected in seminoma JKT-1 cells compared to embryonal carcinoma NTERA-2/D1(NT2/D1), and NCCIT cells (Fig. 1C). This evidence concerns the gene CD44 and embryonal carcinoma.